{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:27:39Z","timestamp":1789100859137,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009010","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alaxia SAS"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vertex"},{"DOI":"10.13039\/100009010","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vectura"},{"DOI":"10.13039\/100009010","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"EU\/EFPIA Innovative Medicines Initiative Joint Undertaking iABC","doi-asserted-by":"publisher","award":["115721"],"award-info":[{"award-number":["115721"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.pupt.2019.101834","type":"journal-article","created":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T01:05:48Z","timestamp":1566090348000},"page":"101834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)"],"prefix":"10.1016","volume":"58","author":[{"given":"Michael R.","family":"Loebinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Polverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Elborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm AWM.","family":"Tiddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhild","family":"Angyalosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2019.101834_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004-2013: a population based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pupt.2017.04.010","article-title":"Cough and bronchiectasis","volume":"47","author":"McCallion","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2019.101834_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chronic Respir. Dis."},{"key":"10.1016\/j.pupt.2019.101834_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/17512433.2018.1421064","article-title":"The pharmacological treatment of bronchiectasis","volume":"11","author":"Melani","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2019.101834_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"Wilson","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2019.101834_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0035-1547346","article-title":"Inhaled antibiotics in cystic fibrosis (CF) and non-CF bronchiectasis","volume":"36","author":"Tay","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101834_bib8","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/jac\/dkx293","article-title":"Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?","volume":"72","author":"Bos","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pupt.2019.101834_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00090314","article-title":"Inhaled antibiotics: dry or wet?","volume":"44","author":"Tiddens","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib10","article-title":"Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis","volume":"3","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2019.101834_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0954-6111(99)90090-2","article-title":"Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa","volume":"93","author":"Orriols","year":"1999","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2019.101834_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101834_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pupt.2019.101834_bib14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2019.101834_bib15","first-page":"1420","article-title":"A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis","volume":"127","author":"Scheinberg","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2019.101834_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101834_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101834_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fi brosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2019.101834_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2019.101834_bib22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1753465817691239","article-title":"Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence","volume":"11","author":"Hamed","year":"2017","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.pupt.2019.101834_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1479972316661923","article-title":"Antibiotic therapy for stable non-CF bronchiectasis in adults \u2013 a systematic review","volume":"14","author":"Fjaellegaard","year":"2017","journal-title":"Chronic Respir. Dis."},{"key":"10.1016\/j.pupt.2019.101834_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.00163208","article-title":"Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101834_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/17425247.2015.1078309","article-title":"Inhaled antibiotics in the treatment of non-cystic bronchiectasis: clinical and drug delivery perspectives","volume":"13","author":"Sugianto","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.pupt.2019.101834_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.pupt.2019.101834_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ppul.21356","article-title":"Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial","volume":"46","author":"Konstan","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.pupt.2019.101834_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ppul.20594","article-title":"Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety","volume":"42","author":"Geller","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.pupt.2019.101834_bib31","article-title":"Continuous versus intermittent antibiotics for non-cystic fibrosis bronchiectasis (Protocol)","volume":"7","author":"Donovan","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2019.101834_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2019.101834_bib33","article-title":"Continuous versus intermittent antibiotics for bronchiectasis","volume":"6","author":"Donovan","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2019.101834_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1164\/rccm.201310-1747OC","article-title":"Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis","volume":"189","author":"Rowan","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101834_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: new therapies and new perspectives","volume":"6","author":"Chalmers","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2019.101834_bib36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101834_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0097-2017","article-title":"Paediatric lung imaging: the times they are a-changin","volume":"27","author":"Tiddens","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2019.101834_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcf.2016.12.008","article-title":"Chest imaging in cystic fibrosis studies: what counts, and can be counted?","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.pupt.2019.101834_bib39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1164\/rccm.201111-2065OC","article-title":"Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation","volume":"185","author":"Loeve","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553919301920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553919301920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:29:53Z","timestamp":1761082193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553919301920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":39,"alternative-id":["S1094553919301920"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2019.101834","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2019.101834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101834"}}